cisplatinbas
chemotherapi
foundat
treatment
major
nonsmal
cell
lung
cancer
nsclc
patient
howev
cisplatin
resist
still
challeng
issu
molecular
mechan
underli
resist
remain
fulli
explor
ca
depend
ctype
lectin
recent
found
correl
tumourigenesi
studi
mainli
focus
whether
impact
clinic
prognosi
contribut
cisplatin
resist
nsclc
result
found
correl
poor
prognosi
patient
lung
cancer
addit
posit
associ
express
valu
cisplatin
found
suggest
may
impact
cisplatin
sensit
vitro
result
cultur
cell
confirm
could
enhanc
cisplatin
resist
knockdown
led
higher
sensit
cisplatin
cell
experi
show
underli
mechan
includ
inhibit
cisplatininduc
cell
apoptosi
improv
dna
repair
capac
upregul
xpa
express
addit
abl
promot
cell
migrat
without
cisplatin
treatment
collect
find
suggest
potenti
clinic
signific
inhibit
overcom
cisplatin
resist
nsclc
patient
lung
cancer
lead
caus
cancerrel
mortal
worldwid
globocan
project
world
health
organ
http
globocaniarc
fr
approxim
lung
cancer
case
diagnos
nonsmal
cell
lung
cancer
nsclc
platinumbas
chemotherapi
foundat
treatment
nsclc
patient
includ
patient
advanc
diseas
patient
present
relaps
cur
intent
surgeri
commonli
use
chemotherapi
agent
cisdiaminedichloroplatinum
ii
also
known
cisplatin
use
backbon
firstlin
chemotherapi
nsclc
howev
develop
cisplatin
resist
remain
one
challeng
problem
clinic
manag
patient
nsclc
cisplatin
resist
major
caus
treatment
failur
accumul
evid
reveal
multipl
factor
involv
cisplatin
resist
includ
enhanc
dna
repair
evas
apoptosi
drug
transport
defici
reduc
drug
accumul
although
great
advanc
ivyspr
intern
publish
achiev
field
underli
mechan
cisplatin
resist
remain
fulli
explor
recent
role
lectin
tumourigenesi
attract
much
attent
selectin
e
pand
lselectin
promot
lung
metastasi
facilit
format
metastat
microenviron
liver
sinusoid
endotheli
cell
lectin
lsectin
adhes
molecul
import
player
colorect
carcinoma
liver
metastasi
also
known
dcsignr
lsign
ca
depend
ctype
lectin
homologu
dcsign
encod
close
relat
lectin
gene
cluster
chromosom
dcsign
typeii
transmembran
protein
share
similar
genet
structur
protein
function
domain
structur
dcsign
consist
intracellular
ntermin
domain
tandemrepeat
neck
domain
ctype
lectin
carbohydr
recognit
domain
note
dcsignr
express
differ
tissu
express
endotheli
cell
lung
liver
lymph
node
dcsign
express
dendrit
cell
dc
dcsign
long
consid
perform
function
recogn
rang
pathogen
mediat
endocytosi
ligand
emerg
evid
demonstr
differ
role
immun
tumour
progress
receptor
virus
hiv
hcv
sarscov
tuberculosi
influenza
virus
also
recent
identifi
associ
tumorigenesi
level
serum
higher
patient
colon
cancer
healthi
control
subsequ
studi
confirm
could
promot
colon
cancer
liver
metastasi
studi
gastric
cancer
mirror
find
serum
level
increas
patient
gastric
cancer
especi
patient
liver
metastasi
level
strongli
correl
advanc
patholog
stage
find
indic
novel
role
dcsignr
tumour
metastasi
case
lung
cancer
similar
result
observ
patient
metastasi
higher
level
serum
patient
without
metastasi
show
lower
serum
express
compar
healthi
control
base
observ
one
intrigu
issu
whether
contribut
aetiolog
lung
cancer
impact
cisplatin
sensit
studi
mainli
focus
associ
clinic
prognosi
particular
role
cisplatin
resist
lung
cancer
patient
whole
genom
express
data
natur
log
transform
valu
cisplatin
cancer
cell
line
obtain
gdsc
databas
http
wwwcancerrxgeneorg
base
gdsc
releas
total
lung
cancer
cell
line
select
analys
relationship
express
cisplatin
sensit
vitro
wholegenom
mrna
express
inform
detect
affymetrix
human
genom
array
normalis
method
affymetrix
micro
array
suit
algorithm
tcga
lung
squamou
cell
carcinoma
lusc
use
test
relationship
express
patient
prognosi
tcgalusc
dataset
contain
patient
base
clinic
inform
lusc
patient
treat
platinum
chemotherapi
screen
subsequ
analysi
whole
genom
express
data
dataset
gener
rnaseq
obtain
normal
fpkm
data
clinic
inform
download
nci
genom
data
common
gdc
kmplot
softwar
use
assess
prognost
valu
biomark
incorpor
surviv
inform
transcriptom
data
obtain
affymetrix
microarray
geo
tcga
databas
total
nsclc
patient
tcga
geo
includ
kmplot
analysi
associ
express
overal
surviv
os
nsclc
patient
includ
analysi
associ
express
first
progress
time
fp
nsclc
cell
line
obtain
american
type
cultur
collect
atcc
cell
cultur
medium
supplement
foetal
bovin
serum
fb
gibco
compani
penicillin
streptomycin
hyclon
cell
incub
humidifi
atmospher
studi
lentivirus
contain
small
hairpin
rna
shrna
specif
target
human
nonspecif
shrna
shcontrol
group
lentivirus
contain
vector
control
vector
group
purchas
genechem
shanghai
china
human
shrna
use
stabli
silenc
express
lentivirus
contain
use
stabli
overexpress
express
silenc
h
cell
seed
cultur
medium
mix
lentivirus
contain
shrna
nonspecif
shrna
ad
differ
group
cell
name
shcontrol
addit
h
final
multipl
infect
moi
maintain
supernat
replac
normal
cultur
medium
cell
continu
cultur
h
subsequ
experi
transfect
process
lentivirusmedi
overexpress
process
lentivirusmedi
knockdown
describ
detail
total
rna
extract
cell
use
trizol
reagent
revers
transcrib
cdna
revers
transcript
kit
accord
manufactur
protocol
thermo
fisher
scientif
waltham
usa
realtim
quantit
pcr
rtqpcr
carri
sybr
green
master
mix
biorad
hercul
ca
realtim
pcr
detect
system
biorad
hercul
ca
cycl
condit
follow
cycl
denatur
second
amplif
second
gapdh
normal
intern
control
gene
express
calcul
use
method
cell
harvest
lyse
ripa
cell
lysi
buffer
contain
pmsf
phosphatas
inhibitor
bca
protein
assay
kit
beyotim
institut
biotechnolog
use
determin
concentr
protein
extract
supernat
cell
lysat
total
protein
lane
separ
sdspage
gel
transfer
pvdf
membran
millipor
bedford
usa
block
skim
milk
h
room
temperatur
pvdf
membran
incub
primari
antibodi
overnight
wash
incub
membran
three
time
tbst
trisbas
nacl
supplement
membran
incub
horseradish
peroxidas
hrp
conjug
secondari
antibodi
h
room
temperatur
wash
membran
three
time
tbst
blot
visual
ecl
plu
chemidoc
tm
mp
imag
system
biorad
hercul
ca
usa
band
intens
determin
use
imag
lab
softwar
version
biorad
antibodi
use
follow
cell
stabli
transfect
lentivirus
reseed
plate
attach
cisplatin
increas
concentr
ad
well
twentyfour
hour
later
cell
count
beyotim
institut
biotechnolog
use
determin
cell
viabil
accord
manufactur
instruct
stabl
knockdown
overexpress
cell
reseed
plate
treat
without
cisplatin
h
accord
group
assign
subsequ
cell
harvest
centrifug
wash
resuspend
coldpb
incub
annexin
vfitc
propidium
iodid
pi
bd
bioscienc
min
room
temperatur
dark
cell
apoptosi
rate
analys
fc
addit
total
cellular
protein
extract
use
measur
express
cleav
western
blot
analysi
cell
migrat
assay
perform
use
transwel
migrat
chamber
pore
size
corn
usa
cell
suspens
contain
fb
ad
upper
chamber
lower
chamber
fill
cultur
medium
contain
fb
twentyfour
hour
later
noninvad
cell
upper
chamber
remov
invad
cell
lower
chamber
stain
hexamethyl
pararosanilin
repres
photo
taken
use
microscop
nikon
instrument
inc
japan
stereomicroscop
nikon
instrument
inc
japan
mean
two
continu
normal
distribut
variabl
compar
independ
sampl
student
test
kruskalw
test
mannwhitney
u
test
use
compar
nonnorm
continu
variabl
linear
regress
use
test
relationship
two
quantit
charact
cox
regress
util
conduct
surviv
analysi
log
rank
test
use
compar
kaplanmei
surviv
curv
analys
conduct
spss
softwar
version
ibm
softwar
inc
new
york
ny
usa
kaplanmei
curv
scatter
plot
drawn
graphpad
prism
graphpad
softwar
inc
san
diego
ca
usa
select
best
cut
valu
median
tertil
quartil
valu
use
divid
sampl
high
express
low
express
group
twotail
p
valu
consid
statist
signific
tcgalusc
dataset
adjust
age
express
level
significantli
associ
os
patient
cox
divid
sampl
two
group
high
express
group
vs
low
express
group
upper
quartil
best
cutoff
valu
use
found
subject
low
express
longer
os
logrank
ci
similar
result
found
analys
kmplot
nsclc
sampl
patient
higher
express
shorter
os
logrank
ci
fp
logrank
ci
lower
express
kaplanmei
curv
tcgalusc
kmplot
nsclc
sampl
shown
figur
ac
success
knock
human
lung
cancer
cell
line
figur
also
observ
remark
increas
express
mrna
protein
level
demonstr
clecm
success
overexpress
figur
stabl
knockdown
overexpress
cell
line
use
subsequ
experi
determin
whether
influenc
sensit
lung
cancer
cell
line
cisplatin
investig
impact
cell
prolifer
gdsc
dataset
express
posit
correl
cisplatin
ic
valu
lung
cancer
cell
line
shown
figur
detail
inform
lung
cancer
cell
line
shown
tabl
vitro
result
also
show
cisplatin
treatment
combin
knockdown
significantli
decreas
cell
viabil
compar
cisplatin
treatment
alon
figur
cell
figur
concentr
cisplatin
treatment
increas
valu
cisplatin
cell
decreas
compar
cell
find
observ
cell
contrast
knockdown
observ
overexpress
increas
cell
viabil
pronouncedli
upon
cisplatin
treatment
figur
cell
figur
valu
cisplatin
higher
cell
cell
result
show
enhanc
cisplatin
resist
lung
cancer
cell
next
annexin
vfitcpistain
cell
detect
flow
cytometri
fc
investig
effect
express
cell
apoptosi
induc
cisplatin
shown
figur
cisplatin
promot
cell
apoptosi
across
cell
knockdown
significantli
enhanc
cisplatininduc
cell
apoptosi
cell
contrast
overexpress
attenu
cisplatininduc
cell
apoptosi
cell
figur
cleav
relev
indic
cell
apoptosi
found
cisplatin
treatment
led
signific
increas
cleav
express
knockdown
upregul
cisplatininduc
cleav
express
figur
overexpress
reduc
cisplatininduc
cleav
express
figur
xpg
xpa
key
player
dna
repair
pathway
result
show
could
regul
xpa
express
cell
knockdown
inhibit
xpa
mrna
protein
express
figur
convers
overexpress
upregul
xpa
mrna
level
cell
upregul
protein
observ
cell
figur
addit
detect
effect
cell
migrat
abil
consist
previou
studi
observ
cisplatin
decreas
migrat
lung
cancer
cell
upon
cisplatin
treatment
cell
knockdown
show
reduc
migrat
abil
compar
control
group
figur
figur
convers
overexpress
promot
cell
migrat
allevi
inhibitori
effect
cisplatin
cell
migrat
figur
figur
cisplatin
resist
major
obstacl
improv
clinic
efficaci
treatment
advanc
nsclc
patient
studi
mainli
investig
biolog
effect
cisplatin
resist
result
show
associ
poor
patient
os
fp
posit
associ
express
valu
cisplatin
suggest
may
impact
cisplatin
sensit
vitro
result
cell
confirm
could
enhanc
cisplatin
resist
knockdown
could
significantli
increas
cisplatin
sensit
experi
show
inhibit
cisplatininduc
cell
apoptosi
improv
dna
repair
capac
upregul
xpa
express
among
underli
mechan
addit
found
could
promot
cell
migrationwith
without
cisplatin
treatment
ctype
lectin
mainli
local
endotheli
cell
liver
lung
lymph
node
previous
identifi
receptor
bind
intern
potenti
ligand
especi
virus
recent
clinic
signific
cancer
investig
high
level
serum
may
potenti
molecular
marker
diagnosi
earli
stage
colon
cancer
biolog
effect
lung
cancer
remain
unclear
current
studi
prognost
analysi
lusc
patient
nsclc
patient
demonstr
patient
higher
express
show
poorer
os
well
shorter
fp
result
indic
could
lead
wors
clinic
outcom
lung
cancer
patient
cisplatin
resist
major
reason
neg
prognosi
nsclc
patient
studi
verifi
initi
specul
promot
cisplatin
resist
cell
line
forc
express
greater
valu
cisplatin
find
indic
poor
clinic
outcom
patient
higher
express
may
result
enhanc
cisplatin
resist
cisplatin
bind
dna
form
dna
adduct
induc
dna
damag
tumour
cell
apoptosi
multipl
mechan
respons
cisplatin
resist
one
predomin
mechan
defect
apoptosi
clear
apoptosi
defect
promot
carcinogenesi
also
lead
chemoresist
result
current
studi
show
cisplatin
significantli
induc
apoptosi
nsclc
cell
knockdown
enhanc
cisplatininduc
apoptosi
consist
overexpress
inhibit
cisplatininduc
apoptosi
result
indic
suppress
cisplatininduc
apoptosi
therebi
lead
cisplatin
resist
nsclc
cell
apoptot
signal
regul
sever
level
caspas
essenti
regul
process
apoptosi
regul
recogn
key
player
control
cellular
apoptosi
upon
receiv
signal
upstream
activ
inact
precursor
convert
activ
form
respons
major
cellular
destruct
result
show
suppress
upregul
cleav
induc
cisplatin
nsclc
cell
express
suppress
cisplatininduc
upregul
cleav
increas
suggest
inhibit
cisplatininduc
apoptosi
nsclc
cell
might
molecular
underpin
role
cisplatin
resist
dna
repair
capac
drc
tumour
cell
substanti
impact
cisplatin
sensit
andor
resist
nucleotid
excis
repair
ner
consid
import
way
sens
respond
cisplatininduc
dna
damag
four
step
follow
remov
dna
lesion
ner
recognit
dna
unwind
incis
endonucleas
dna
resynthes
earli
stage
clinic
studi
reveal
elev
drc
could
enhanc
cisplatin
resist
nsclc
cell
line
subsequ
studi
also
demonstr
drc
independ
predictor
clinic
outcom
nsclc
patient
treat
cisplatinbas
chemotherapi
compon
ner
seri
protein
display
distinct
function
dna
repair
implic
dna
incis
receiv
much
attent
regard
role
platinum
resist
xpa
protein
bind
damag
site
dna
provid
dock
site
excis
xpa
express
upregul
cultur
nsclc
cell
line
resist
cisplatin
resist
result
show
knockdown
inhibit
xpa
express
cell
convers
overexpress
upregul
xpa
express
cell
mrna
level
xpa
also
increas
cell
increas
protein
level
obviou
howev
reason
differ
observ
cell
clear
extent
current
result
suggest
dcsignr
may
enhanc
dna
repair
increas
xpa
express
howev
detect
direct
dna
repair
capac
molecular
action
also
need
elucid
final
found
promot
migrat
cell
without
cisplatin
treatment
knockdown
express
remark
inhibit
migrat
nsclc
cell
line
observ
promot
invas
colon
cancer
cell
role
tumour
metastasi
report
exampl
promot
colon
cancer
gastric
cancer
liver
metastasi
nsclc
patient
serum
level
higher
patient
metastasi
without
metastasi
collect
find
confirm
role
nsclc
migrat
conclus
best
knowledg
first
report
demonstr
higher
express
associ
poor
clinic
prognosi
lung
cancer
patient
enhanc
resist
nsclc
cell
cisplatin
inhibit
express
significantli
increas
cisplatin
sensit
suggest
potenti
clinic
signific
target
overcom
cisplatin
resist
howev
limit
exist
studi
underli
molecular
mechan
signal
pathway
regul
apoptosi
dna
repair
remain
elucid
